Strong Organic Revenue Growth
GE Healthcare reported a 4% organic revenue growth year-over-year, driven by solid customer demand and robust orders growth of 6% across all segments.
Significant Backlog and Order Growth
The company exited the quarter with a backlog of $21.2 billion, with a strong book-to-bill ratio of 1.06x and trailing four-quarter orders growth at 6%.
Successful Strategic Partnerships
Partnerships such as the 14-year Care Alliance with UC San Diego Health and the planned acquisition of icometrix highlight strategic initiatives to strengthen product portfolios and drive growth.
Impressive Performance in Pharmaceutical Diagnostics
The Pharmaceutical Diagnostics segment delivered a 10% organic sales growth year-over-year, with a 14% EBIT growth.
Raised Adjusted EPS Guidance
Due to strong performance year-to-date, GE Healthcare raised its adjusted EPS guidance for the full year, reflecting confidence in future performance.